CANVAS-COVID Study Results

Results as of: September 1, 2021

Total persons enrolled in study

1 242 520

Vaccination dose received and survey completed:

DOSE 1

survey  completed

700,270

DOSE 2

survey  completed

337,091

People experiencing local reaction:

52%

Injection site pain/swelling/redness

Other health events that occurred after dose 1:

0%

8%

of people developed a new health event within 7 days of receiving their first dose

58,524 out of 700,270 doses

0%

5%

of people developed a new health event within 7 days that prevented daily activities/
work/required a medical visit

34,900 out of 700,270 doses

Other health events that occurred after dose 2:

0%

9%

of people developed a new health event within 7 days of receiving their second dose

28,825 out of 337,091 doses

0%

5%

of people developed a new health event within 7 days of receiving their second dose that prevented daily activities/work/required a medical visit

16,891 out of 337,091 doses

Most frequent other health events reported:

4.4%

Systemic symptoms

(fever, fatigue, muscle ache, feeling unwell)

3.2%

Headache or migraine

1.9%

Nausea, vomiting, diarrhea

Other events of interest:

Shingles is not occurring more frequently after vaccination

VACCINATED GROUP

0.02%

UNVACCINATED GROUP

0.03%